Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR
Alessandra Mangolini(University of Ferrara), Massimo Negrini(University of Ferrara), Manuela Ferracin(University of Ferrara), Elena Saccenti(University of Ferrara), Juana María Sanz(University of Ferrara), Maria Vittoria Zanzi(University of Ferrara), Patrizia Querzoli(University of Ferrara), Valentina Vultaggio-Poma(University of Ferrara), Sayda Omer Ebnaof(University of Ferrara), Antonio Frassoldati(University of Ferrara), Massimo Pedriali(University of Ferrara), Angelina Passaro(University of Ferrara), Silvia Sabbioni(University of Ferrara), Paolo Carcoforo(University of Ferrara), Alan B. Hollingsworth(Mercy Medical Center)
Cited by 94
Related Papers
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
|Annals of Oncology|2012|337
Isolation and characterization of CD146+ multipotent mesenchymal stromal cells
|Experimental Hematology|2008|254
Oncogenic Role of <i>miR-483-3p</i> at the <i>IGF2/483</i> Locus
|Cancer Research|2010|213
Greater loss in muscle mass and function but smaller metabolic alterations in older compared with younger men following 2 wk of bed rest and recovery
|Journal of Applied Physiology|2016|146